The shedding of soluble MICA by human tumors not only hinders recognition of the MICA-expression tumor cells, but also results in systemic downregulation of NKG2D on NK and CD8+ T cells, and evasion of NKG2D-mediated immune recognition 30,31. The gene discussed is KLRK1; the disease is neoplasm.